Why the study?
Does a long-PCR-based method accurately detect Familial Hyperaldosteronism Type I across all age groups?
Does a long-PCR-based method accurately detect Familial Hyperaldosteronism Type I across all age groups?
Long-PCR is a reliable and rapid method for screening individuals of all ages for Familial Hyperaldosteronism Type I, enabling early detection and targeted treatment to prevent severe complications like stroke.
Answers are grounded in this paper and cite their sources.
Long-PCR may aid FH-I family screening; leaves open prospective validation before changing practice.
AIM: Unless specifically treated (glucocorticoids in low doses), Familial Hyperaldosteronism Type I (FH-I) may result in early death from stroke. We report the successful application of a rapid, polymerase chain reaction (PCR)-based method of detecting the 'hybrid' 11 beta-hydroxylase (11 beta-OHase)/aldosterone synthase (AS) gene as a screening test for FH-I. METHODS: 'Long-PCR' was used to amplify, concurrently, a 4 kb fragment of AS gene (both primers AS-specific) and a 4 kb fragment of the hybrid gene (5' primer 11 beta-OHase-specific, 3' primer AS-specific) from DNA extracted from blood either collected locally or transported from elsewhere. Sample collection and transport were straightforward. This 4 kb fragment contains all the currently recognised hybrid gene 'crossover' points. RESULTS: Within a single family, long-PCR identified all 21 individuals known to have FH-I. Hypertension was corrected in all 11 treated with glucocorticoids. Nine with normal blood pressure are being closely followed for development of hypertension. Long-PCR cord blood analysis excluded FH-I in three neonates born to affected individuals. Long-PCR newly identified two other affected families: (1) a female (60 years) with a personal and family history of stroke and her normotensive daughter (40 years), and (2) a female (51 years) previously treated for primary aldosteronism with amiloride, her two hypertensive sons (14 and 16 years) and her hypertensive mother (78 years). No false negative or false positive results have yet been encountered. At least seven other centres have successfully performed this test. CONCLUSION: Long-PCR is a reliable method of screening individuals of all ages for FH-I.
No takes yet. Share an insight, caveat, or question.
Stowasser et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: